These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28941499)

  • 1. Genomic Investigation of Lupus in the Skin.
    Sinha AA; Dey-Rao R
    J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S75-S80. PubMed ID: 28941499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential gene expression analysis in CCLE lesions provides new insights regarding the genetics basis of skin vs. systemic disease.
    Dey-Rao R; Smith JR; Chow S; Sinha AA
    Genomics; 2014 Aug; 104(2):144-55. PubMed ID: 24956118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetics of cutaneous lupus erythematosus.
    Hersh AO; Arkin LM; Prahalad S
    Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide transcriptional profiling of chronic cutaneous lupus erythematosus (CCLE) peripheral blood identifies systemic alterations relevant to the skin manifestation.
    Dey-Rao R; Sinha AA
    Genomics; 2015 Feb; 105(2):90-100. PubMed ID: 25451738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies.
    Lee HJ; Sinha AA
    Autoimmunity; 2006 Sep; 39(6):433-44. PubMed ID: 17060022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.
    Dey-Rao R; Sinha AA
    BMC Genomics; 2017 Jan; 18(1):109. PubMed ID: 28129744
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Dey-Rao R; Sinha AA
    Front Immunol; 2019; 10():640. PubMed ID: 30984198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p.
    Lee-Kirsch MA; Gong M; Schulz H; Rüschendorf F; Stein A; Pfeiffer C; Ballarini A; Gahr M; Hubner N; Linné M
    Am J Hum Genet; 2006 Oct; 79(4):731-7. PubMed ID: 16960810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of specific cutaneous manifestations in patients with lupus erythematosus: a time for change? The concept of dermal lupus erythematosus.
    Lipsker D
    Dermatology; 2006; 212(4):324-6. PubMed ID: 16707881
    [No Abstract]   [Full Text] [Related]  

  • 11. Not Just Skin Deep: Systemic Disease Involvement in Patients With Cutaneous Lupus.
    O'Brien JC; Chong BF
    J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S69-S74. PubMed ID: 28941498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
    Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
    Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study identifies new susceptibility loci for cutaneous lupus erythematosus.
    Kunz M; König IR; Schillert A; Kruppa J; Ziegler A; Grallert H; Müller-Nurasyid M; Lieb W; Franke A; Ranki A; Panelius J; Koskenmies S; Hasan T; Kere J; Rönn AC; Simon JC; Schmidt E; Wenzel J; Tüting T; Landsberg J; Zeller T; Blankenberg S; Gläser R; Patsinakidis N; Kuhn A; Ibrahim SM
    Exp Dermatol; 2015 Jul; 24(7):510-5. PubMed ID: 25827949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations of cutaneous lupus erythematosus.
    Werth VP
    Autoimmun Rev; 2005 Jun; 4(5):296-302. PubMed ID: 15990077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunopathology of cutaneous lupus erythematosus.
    Kirchhof MG; Dutz JP
    Rheum Dis Clin North Am; 2014 Aug; 40(3):455-74, viii. PubMed ID: 25034156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Skin manifestations of lupus erythematosus].
    Harr T; Bircher AJ; Häusermann P
    Ther Umsch; 2005 May; 62(5):303-12. PubMed ID: 15945221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations.
    Koskenmies S; Järvinen TM; Onkamo P; Panelius J; Tuovinen U; Hasan T; Ranki A; Saarialho-Kere U
    Lupus; 2008 Apr; 17(4):337-47. PubMed ID: 18413417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray study reveals a transforming growth factor-β-dependent mechanism of fibrosis in discoid lupus erythematosus.
    Solé C; Gimenez-Barcons M; Ferrer B; Ordi-Ros J; Cortés-Hernández J
    Br J Dermatol; 2016 Aug; 175(2):302-13. PubMed ID: 26972571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratinocyte and lymphocyte apoptosis: relation to disease outcome in systemic lupus erythematosus patients with and without cutaneous manifestations.
    Salem SA; Farouk HM; Mostafa AA; Hassan IM; Osman WM; Al-Shamy HA; Assaf NY
    Eur J Dermatol; 2010; 20(1):35-41. PubMed ID: 19919906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.